Design and characterization of controlled release matrix tablets of zidovudine

Asian Journal of Pharmaceutical and Clinical Research

Volumn 2, Issue 2, 2009, Pages 54-61

  Kar, R K ^a   Mohapatra, S ^a   Barik, B B ^b  

^a Jeypore College of Pharmacy   (India)

^b UTKAL UNIVERSITY   (India)

Author keywords

Controlled release; Matrix tablets; Release kinetics; Zidovudine

Indexed keywords

ETHYL CELLULOSE; EUDRAGIT; EUDRAGIT RS; MICROCRYSTALLINE CELLULOSE; ZIDOVUDINE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DESIGN; DRUG RELEASE; DRUG SOLUBILITY; MATHEMATICAL ANALYSIS; TABLET COMPRESSION;

EID: 77953375004     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Chien Y W, "Novel Drug Delivery Systems," ed. by Chien Y. W., Marcel Dekker, Inc., New York, U.S.A., 1992, pp. 139-196.
2. Vyas SP, Khar R K, "Controlled Drug Delivery: Concepts and Advances," ed. by Vyas S. P., Khar R K, Vallabh Prakashan, Delhi,2002; pp. 155-195.
3. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO). "AIDS epidemic update 2005," Geneva: UNAIDS. Available at: http://www.unaids.org/epi/2005/doc/EPI-update2005-pdf-en/ epiupdate2005-en.pdf. Accessed 10 December,2006.
4. Richman D., Fischl M M, Grieco M H, Gottlieb M S, Volberding P A, Laskin O L, Leedom J M, Groopman J E, Mildvan D., Hirsch M S, Jackson G, Durack D T., Phil D., Nusinoff-Lehrman S., N. Engl. J. Med., 1987;317: 192-197.
5. Lewis L D, Amin S., Civin C I, Lietman P S, Hum. Exp. Toxicol., 2004;23, 173-185.
6. Kieburtz KD, Seidllin M, Lambert JS, Dollis R, Reichman R, Valentine T. Extended follow-up of neuropathy in patients with AIDS and AIDS related complex treated with dideoxyinosine. J Acquir Immuno Defic Syndrom. 1992;5:60Y64.
7. Chitnis S, Mondal D, Agrawal K C, Life Sci., 2002:12; 967-978.
8. Chariot P, Drogou I., de Lacroix-Szmania I., Eliezer-Vanerot M. C., Chazaud B., Lombes A., Schaeffer A., Zafrani E. S., J. Hepatol., 1999:30; 156-160.
9. Re M. C., Bon I., Monari P., Gorini R., Schiavone P., Gibellini D., La Placa M., New Microbiol., 2003;26: 405-413.
10. Salsa T, Veiga F, Pina ME. Oral controlled-release dosage forms. I. Cellulose ether polymers in hydrophilic matrices. Drug Dev Ind Pharm. 1997;23:929Y938.
11. Vargas C L, Ghaly E S, Drug Dev. Ind. Pharm., 1999;25: 1045-1050.
12. Ranga R K V, Padmalatha D K, Buri B, Drug Dev. Ind. Pharm., 1988;14: 2299-2320.
13. Parojcic J, Duric Z, Jovanovic M, Ibric S, Drug Delivery, 2004;11: 59-65.
14. Korsenmeyer R W, Peppas N A, "Macromolecular and Modeling Aspects of Swelling-Controlled Systems," ed. by Mansdorf S. Z., Roseman T. J., Marcel Dekker Inc., New York, 1983, p. 77.
15. Alderman DA. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr. 1984;5:1Y9.
16. Liu J, Zhang F, McGinity JW. Properties of lipophilic matrix tablets containing phenylpropanolamine hydrochloride prepared by hot-melt extrusion. Eur J Pharm Biopharm. 2001;52:181Y190.
17. Government of India Ministry of Health and Family Welfare. The Pharmacopoeia of India. Delhi, India: Controller of Publication; 1996.
18. Gohel M.C., Panchal M.K., Pharm. Tech., 2001; 9: 62.
19. Al-Taani BM, Tashtoush BM. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium. AAPS PharmSciTech. 2003; 4:E43.
20. nd Ed., 1995; pp. 538-550.
21. Ebube N.K., Hikal A., Wyandt C.M., Beer D.C., Miller L.G. and Jones A.B.: Susatained release of acetomenophen from heterogeneous matrix tablets, influence of polymer ratio, polymer loading and coactive on drug release, phar Dev Technol. 1997;2: 161-170.